Stay updated on Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Sign up to get notified when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.

Latest updates to the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a new site revision tag (v3.4.2); removed a government-funding notice and an older revision tag (v3.4.1).SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display option and exposed the QC status label (Last Update Submitted that Met QC Criteria); the site revision was updated from v3.3.4 to v3.4.0 with related wording adjustments.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No study details or content are affected.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter updates: the page now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed; the previous Revision: v3.3.2 entry is no longer present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.